NCT06201299 Chair-based and Standard Exercise Programs in People With COPD
| NCT ID | NCT06201299 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Medipol University Hospital |
| Condition | COPD |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2024-01-20 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2024-01-20 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients who are diagnosed with COPD by a pulmonology specialist and referred to pulmonary rehabilitation will be included in the study. Cases that meet the inclusion criteria will be randomized and divided into two groups, standard exercise program group (SGr) and chair-based exercise. program group will be called (ChGr). While standard exercises will be given to SGr, chair-based exercises will be applied to ChGr. All evaluation and initial training sessions of the cases will be held in the hospital. Apart from this, they will be asked to do their exercises at home with the exercise videos that will be sent to them. In order to ensure that home exercises are performed completely and correctly, 2 sessions of online simultaneous exercise training will be provided with a physiotherapist via videoconference on a smartphone, and exercise follow-ups will be carried out by calling once a week. The program duration is 8 weeks, 5 days a week.
Eligibility Criteria
Inclusion Criteria: * Being between the ages of 18-75 years * Having a diagnosis of COPD diagnosed according to clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS). * Presence of dyspnea on exertion * Stable clinical status at inclusion without infection or exacerbation in the previous 4 weeks \*Having smart phone usage skills Exclusion Criteria: * Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and requiring high-flow oxygen therapy (˃ 3-4 L\\min). * A history of exertional syncope or the presence of any comorbidities (such as severe orthopedic or neurological deficits or unstable heart disease) that preclude exercise training. * Having participated in a pulmonary rehabilitation program within the last 12 months.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06201299 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06201299 currently recruiting?
Yes, NCT06201299 is actively recruiting participants. Contact the research team at fztesrakambur@yahoo.com for enrollment information.
Where is the NCT06201299 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06201299 clinical trial?
NCT06201299 is sponsored by Istanbul Medipol University Hospital. The trial plans to enroll 64 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.